Reuters logo
2 个月前
BRIEF-Otsuka announces results of phase 3 data on tolvaptan
2017年5月22日 / 中午12点11分 / 2 个月前

BRIEF-Otsuka announces results of phase 3 data on tolvaptan

1 分钟阅读

May 22 (Reuters) - Otsuka Holdings Co Ltd

* Otsuka announces results of phase 3 data on tolvaptan

* Says primary and key secondary endpoints were positive for tolvaptan versus placebo in an additional phase 3 clinical trial

* Data are intended to address complete response letter issued by FDA for a new drug application for tolvaptan in ADPKD in 2013

* Says there were no new safety issues identified for tolvaptan during trial Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below